tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND
Advertisement

Ligand Pharma (LGND) Similar Stocks

Compare
821 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ligand Pharma
$181.65
$3.54B
48.01
70.74%
6 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$24.52
$3.05B
-12.18%
10 Buy
6 Hold
1 Sell
Moderate Buy
Scholar Rock Holding
$27.94
$2.83B
-8.54%
12 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$41.57
$3.98B
-29.65%
15 Buy
1 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$59.83
$4.32B
29.36%
18 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$9.12
$602.48M
-81.36%
8 Buy
8 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LGND
Ligand Pharma
181.65
74.87
70.12%
APLS
Apellis Pharmaceuticals
24.52
-2.36
-8.78%
SRRK
Scholar Rock Holding
27.94
-2.02
-6.74%
CRNX
Crinetics Pharmaceuticals
41.57
-17.13
-29.18%
KYMR
Kymera Therapeutics
59.83
13.27
28.50%
MLTX
MoonLake Immunotherapeutics
9.12
-39.90
-81.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis